title: Infliximab in a patient with refractory mucosal aphthosis.
authors.forename: A
authors.initials: A
authors.lastname: Jacobi
authors.forename: D
authors.initials: D
authors.lastname: Debus
authors.forename: G
authors.initials: G
authors.lastname: Schuler
authors.forename: M
authors.initials: M
authors.lastname: Hertl
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D003424:Crohn Disease / Q000150:complications; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D000069285:Infliximab; D008875:Middle Aged; D009092:Mucous Membrane / Q000473:pathology; D013281:Stomatitis, Aphthous / Q000188:drug therapy* / Q000209:etiology / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
chemical_list: D000911:Antibodies, Monoclonal; D003879:Dermatologic Agents; D014409:Tumor Necrosis Factor-alpha; D000069285:Infliximab